Germline testing can detect inherited DNA variants linked to hereditary cancer, yet testing rates remain critically low. Learn how this testing can improve outcomes, guide treatment, and protect your family.
FCS research presented at the 2026 ASCO® Annual Meeting found comparable CAR T-cell therapy outcomes across accredited and non-accredited centers, highlighting the importance of convenient access to care.
Florida Cancer Specialists & Research Institute will showcase 32 abstracts and presentations at the 2026 ASCO® Annual Meeting, highlighting groundbreaking cancer research and advances in precision oncology.
Florida Cancer Specialists & Research Institute highlights expanded initiatives to improve veterans’ access to personalized cancer care, telehealth and clinical trials.
Discover how FCS uses low-dose radiation therapy to help relieve chronic pain and benign conditions such as plantar fasciitis, tendonitis, and keloids.
FCS Top News Updates
FCS Leadership Review of Step Therapy Policies Details Troubling Impacts to Cancer Patients
Hereditary Cancer Spotlight: Importance of Germline TestingGermline testing can detect inherited DNA variants linked to hereditary cancer, yet testing rates remain critically low. Learn how this testing can improve outcomes, guide treatment, and protect your family.
Inspiring Excellence: FCS Leader Receives Prestigious 40 Under 40 in Cancer AwardFCS leader Kiana Mehring, MBA, PPMC, LION, receives the prestigious 40 Under 40 in Cancer Award for advancing value-based oncology care.
FCS Welcomes Medical Oncologist and Hematologist Elke K. Friedman, MD to Stuart Cancer CenterFCS welcomes medical oncologist and hematologist Dr. Elke K. Friedman to its Stuart clinic, expanding cancer care services in Martin County.
From the Heart of Cancer SurvivorsIn honor of National Cancer Survivors Day, see the words cancer survivors chose to describe their journeys and find encouragement for the road ahead.
FCS Study Finds Comparable Quality and Safety Outcomes in CAR T-Cell Therapy Across Accredited and Non-Accredited Centers, Highlighting Care Location as Key Driver of Patient Access and ExperienceFCS research presented at the 2026 ASCO® Annual Meeting found comparable CAR T-cell therapy outcomes across accredited and non-accredited centers, highlighting the importance of convenient access to care.
FCS Advances the Future of Cancer CareFlorida Cancer Specialists & Research Institute will showcase 32 abstracts and presentations at the 2026 ASCO® Annual Meeting, highlighting groundbreaking cancer research and advances in precision oncology.
FCS Highlights Ongoing Innovation to Expand Veteran Access to Advanced Cancer CareFlorida Cancer Specialists & Research Institute highlights expanded initiatives to improve veterans’ access to personalized cancer care, telehealth and clinical trials.
Relief for Chronic PainDiscover how FCS uses low-dose radiation therapy to help relieve chronic pain and benign conditions such as plantar fasciitis, tendonitis, and keloids.